TG THERAPEUTICS INC
TGTX · NASDAQ
更新於 2026-10-14 12:38:00
$54.34-1.68%
- 今日最高
- $55.39
- 今日最低
- $53.63
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $55.38
- 昨天收盤價
- $55.27
- 成交量
- 758.15K
- 市值
- $8.46B
- 市盈率（P/E）
- 19.19X
- 每股收益（EPS）
- $2.74
昨天價格區間
$54.65$55.86
52週價格區間
$26.76$59.30
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 3020 CARRINGTON MILL BLVD., MORRISVILLE, NC, UNITED STATES, 27560
- 國家
- 美國
- 上市日期
- 1995-12-14
- 財年截止
- 十二月
- 流通股數
- 153.08M
- CIK
- 0001001316
TG Therapeutics, Inc. 是一家處於商業化階段的生物製藥公司，專注於收購、開發及商業化用於治療B細胞惡性腫瘤及自身免疫性疾病的新型療法。公司總部位於紐約州紐約市。
財務指標
營業收入
2026-06-30
$240.33M
2026-03-31
$204.91M
2025-12-31
$192.57M
2025-09-30
$161.7M
營業支出
2026-06-30
$177.46M
2026-03-31
$136.61M
2025-12-31
$103.93M
2025-09-30
$104.18M
淨利潤
2026-06-30
$7.78M
2026-03-31
$19.77M
2025-12-31
$23.03M
2025-09-30
$390.89M
淨利潤率
2026-06-30
3.23%
2026-03-31
9.65%
2025-12-31
11.96%
2025-09-30
241.72%
每股收益
2026-06-30
$0.05
2026-03-31
$0.18
2025-12-31
$0.14
2025-09-30
$0.16
息稅折舊攤銷前利潤
2026-06-30
$21.77M
2026-03-31
$28.1M
2025-12-31
$51.69M
2025-09-30
$32.69M
有效稅率
2026-06-30
23.96%
2026-03-31
2.87%
2025-12-31
48.91%
2025-09-30
-1.4K%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $240.33M | $204.91M | $192.57M | $161.7M |
| 營業支出 | $177.46M | $136.61M | $103.93M | $104.18M |
| 淨利潤 | $7.78M | $19.77M | $23.03M | $390.89M |
| 淨利潤率 | 3.23% | 9.65% | 11.96% | 241.72% |
| 每股收益 | $0.05 | $0.18 | $0.14 | $0.16 |
| 息稅折舊攤銷前利潤 | $21.77M | $28.1M | $51.69M | $32.69M |
| 有效稅率 | 23.96% | 2.87% | 48.91% | -1.4K% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。